Supplements for Joint Pain in Menopause: What Works, and For How Long
Four in ten women have muscle or joint pain before menopause. Among perimenopausal women it is 57%, and after menopause 59%. Those figures come from 37 studies across 22 countries covering 93,021 women, and they describe something most women in their late forties already know from the inside.
The supplement aisle has noticed. Walk into any pharmacy and there is a shelf of joint formulas, several of them now marketed at menopause specifically, most built around glucosamine and chondroitin, some around turmeric, an increasing number around collagen. The question is which of them survive contact with the evidence.
Sixty-nine randomized trials have tested twenty different supplements for joint pain. This article covers what they found, which supplements do best and which do worst, where collagen lands, one thing nobody has ever tested, and one finding about durability that almost no page selling these products will tell you.
- How common joint pain is in midlife
- The thing nobody has tested
- Supplements for joint pain in menopause: what the trials found
- The two most women take are the two with the weakest evidence
- Where collagen lands
- The finding nobody quotes
- Where Botavive Collagen Powder fits
- The bottom line
- Frequently asked questions
| The claim | What the evidence shows |
|---|---|
| Joint pain rises around menopause | Supported. Across 93,021 women it rises from 40% premenopausal to 57% perimenopausal and 59% postmenopausal, a 1.40-fold increased risk |
| Supplements have been tested for menopause joint pain | They have not. Every trial in both major reviews enrolled osteoarthritis patients, not women with menopause-related joint pain |
| Glucosamine and chondroitin are the reliable choice | They are the least impressive. Both showed statistically significant pain improvement of unclear clinical importance across 69 trials |
| Collagen has evidence behind it | Yes, for short-term pain. Collagen hydrolysate was one of seven supplements with large effects, meaning an effect size above 0.80 |
| Collagen is the best option available | No. In a 2025 network meta-analysis of 4,599 patients, Boswellia ranked highest for pain and stiffness, with collagen benefiting some outcomes |
| These effects last if you keep taking them | Unproven. No supplement of the twenty had clinically important effects on pain at long-term follow-up |
How common joint pain is in midlife
Start with the size of the thing, because it is routinely underestimated by everyone except the women experiencing it.
A 2026 systematic review in JB and JS Open Access screened 5,556 records and pooled 37 observational studies from 22 countries, covering 93,021 women. Muscle or joint pain affected 40% of women in the premenopausal phase. Among perimenopausal women that rose to 57%, and among postmenopausal women to 59%. Expressed as risk, perimenopausal women were 1.35 times more likely to report it than premenopausal women, and postmenopausal women 1.40 times more likely, both at p less than 0.001 (Kruse et al., 2026).
In absolute terms that is roughly 148 more women per thousand after menopause than before. If joint pain arrived in your mid-forties and nobody connected it to anything hormonal, those numbers are the context that was missing from the conversation.
What the review is careful about, and so should we be. Every one of the 37 studies was observational, which establishes that the pain and the menopausal transition occur together, not that one causes the other. The heterogeneity between studies was very high, 88.6% and 95.0% on the two comparisons, and neither geography nor the measurement scale used explained it. The authors also flag that studies overwhelmingly recorded generic "muscle and/or joint pain" without identifying what was wrong with the joint inside. Their own conclusion asks for higher-quality research to confirm the association. Menopause overlaps with a decade of ordinary ageing, and disentangling the two has not been done.
The thing nobody has tested
Here is the gap that shapes everything below, and it is not mentioned on a single page currently ranking for this question.
Sixty-nine randomized trials tested supplements for joint pain in one major review, and 39 more in a second. Every trial in both enrolled people with diagnosed osteoarthritis of the hand, hip or knee. Not one enrolled women with menopause-related joint pain as the condition being treated.
That matters because the two may not be the same thing. Osteoarthritis is a structural disease of cartilage and bone with visible changes on imaging. The joint pain many women describe in perimenopause is diffuse, affects several joints at once, often lacks obvious swelling, and does not necessarily show structural damage. A supplement that reduces pain in a knee with cartilage loss has no automatic claim on a hormone-related ache in the hands, shoulders and hips.
So everything that follows is an extrapolation. It is the best evidence available and it is worth knowing, but any brand telling you a supplement is proven for menopause joint pain is describing trials that were not run.
Supplements for joint pain in menopause: what the trials found
The most thorough analysis remains a 2018 systematic review and meta-analysis in the British Journal of Sports Medicine, which examined 20 supplements across 69 randomized trials, all comparing an oral supplement against placebo (Liu et al., 2018).
Seven supplements produced large and clinically important effects on short-term pain, meaning an effect size above 0.80. In the paper's own order those were collagen hydrolysate, passion fruit peel extract, Curcuma longa extract, Boswellia serrata extract, curcumin, pycnogenol and L-carnitine.
A second group of six showed statistically significant pain improvement but of unclear clinical importance, meaning the effect was real in the statistics and possibly too small for a person to notice: undenatured type II collagen, avocado soybean unsaponifiables, methylsulfonylmethane, diacerein, glucosamine and chondroitin.
A 2025 network meta-analysis in Nutrients then ranked seven supplements directly against each other, pooling 39 randomized trials and 4,599 patients. Boswellia showed the clearest improvements against placebo across WOMAC pain, stiffness and function and on the visual analogue pain scale, and had the highest probability of being the most effective for pain and stiffness. Curcumin, collagen, ginger and krill oil each showed benefits on some outcomes without topping the ranking. No supplement caused more adverse events than placebo (Zhang et al., 2025).
| Supplement | What the evidence shows for joint pain | How it ranked |
|---|---|---|
| Boswellia serrata | Large short-term effect in the 2018 review, and the clearest improvements across pain, stiffness and function in the 2025 ranking | Strongest overall |
| Collagen hydrolysate | Large short-term effect on pain, first named of the seven, and benefit on some outcomes in the 2025 ranking | Strong short term |
| Curcumin and Curcuma longa | Large short-term effect on pain, and potential for improving function in the 2025 ranking | Strong short term |
| Krill oil | Benefit on some outcomes, with potential for function improvement | Moderate |
| Undenatured type II collagen | Improvement of unclear clinical importance short term, but one of only two supplements with a clinically important effect at medium term | Modest but more durable |
| Glucosamine and chondroitin | Statistically significant pain improvement of unclear clinical importance. Described as ineffective or of arguably unimportant benefit | Weakest of the well-known options |
| Any of them, long term | No supplement showed a clinically important effect on pain at long-term follow-up | Unproven |
The two most women take are the two with the weakest evidence
Glucosamine and chondroitin have been the default joint supplement for thirty years. They are in most combination formulas on the shelf, including many now labelled for menopause.
In the 2018 review both landed in the second tier: statistically significant improvement in pain, of unclear clinical importance. The authors did not soften it in the conclusion, describing widely used supplements such as glucosamine and chondroitin as either ineffective or showing small and arguably clinically unimportant treatment effects. Chondroitin did produce a statistically significant structural improvement, an effect size of minus 0.30, which the paper also classes as not clinically important.
Neither appeared in the 2025 network meta-analysis, which restricted itself to seven other supplements, so the newer ranking neither rescues nor further damages them.
This is not a reason to throw out a bottle that helps you. Individual response varies, the safety record is good, and relief you can feel is relief. It is a reason to be sceptical when a menopause joint formula leads with its glucosamine content as though that settles the question.
Where collagen lands
Collagen comes out of this better than most, and it is worth being precise about how much better.
In the 2018 review, collagen hydrolysate was the first named of the seven supplements producing large and clinically important short-term pain effects. That is a genuine result from the most comprehensive analysis available, and it puts collagen ahead of the glucosamine and chondroitin that dominate the category.
In the 2025 ranking, collagen demonstrated benefits on some outcomes but did not finish first. Boswellia did, on pain and on stiffness. Anyone claiming collagen is the best-evidenced supplement for joint pain is overstating a real but second-place finding.
One detail underneath that is worth keeping. Undenatured type II collagen, a different preparation taken at far smaller doses than collagen peptides, was one of only two supplements in the whole review with a clinically important effect at medium term.
Pro Tip: Collagen hydrolysate, collagen peptides, undenatured type II collagen and gelatin are not interchangeable, and the trials used specific ones at specific doses. A label saying only "collagen" tells you very little about which body of evidence, if any, applies to what is in the tub.
The finding nobody quotes
Every page selling joint supplements quotes the short-term results. Here is the sentence they leave out.
Across all 20 supplements and 69 trials, no supplement was identified with clinically important effects on pain reduction at long term. Only two, green-lipped mussel extract and undenatured type II collagen, managed a clinically important effect even at medium term. The same pattern held for physical function.
Two honest readings, and the truth is probably some of each. Either the effects genuinely fade, or long-term trials are expensive, rare and prone to dropout, so an absence of proven long-term effect partly reflects an absence of long-term studies. The review rates overall evidence quality as very low, which cuts both ways.
What it means practically is this. If you try a supplement for joint pain, judge it inside the window where the evidence exists, which is weeks to a few months. If it has done nothing measurable by then, continuing to buy it for another year is not supported by anything. And if it has helped, that is worth having, but nobody has demonstrated it will still be helping in two years.
One more thing the trials keep showing that no supplement outperforms: progressive resistance training. It is the intervention with the most consistent evidence for midlife musculoskeletal symptoms, it also addresses the muscle and bone changes happening at the same time, and it costs nothing.
- See a doctor if a joint is swollen, hot or red, which points at inflammation rather than wear
- See a doctor if morning stiffness regularly lasts more than an hour, which can indicate inflammatory arthritis
- See a doctor about pain in one joint only, particularly after an injury
- Ask for a vitamin D level and a thyroid check, since deficiency and thyroid dysfunction both cause joint pain and both are treatable
- Check with your doctor before starting any supplement if you are pregnant, breastfeeding or taking prescription medication, and note that turmeric and krill oil can interact with blood thinners
Where Botavive Collagen Powder fits
Botavive Collagen Powder provides 20 g of grass-fed bovine collagen peptides per serving, supplying 18 g of protein, types I and III, with 90 mg of hyaluronic acid and 30 mcg of biotin. Unflavored, so it goes into coffee or oatmeal unchanged.
On the evidence above, collagen peptides are a reasonable thing to have in a midlife routine. They carry a large short-term pain result from the most comprehensive review of the field, they beat the glucosamine and chondroitin that dominate the shelf, and they do something for skin and bone at the same time, which is covered elsewhere in this series.
What Botavive is not going to tell you is that this is proven for menopause joint pain, because the trials behind it were run in people with osteoarthritis and nobody has tested it in the condition this article is about. Nor is it the top-ranked supplement for joint symptoms, since Boswellia holds that position. Collagen is a defensible choice with real short-term evidence, sitting alongside resistance training rather than replacing it.
The bottom line
The pain is real and it is common. Across 93,021 women, muscle and joint pain rises from 40% before menopause to 59% after, and the women reporting it are not imagining a pattern.
The supplements sold for it have been tested, though never in this exact population. Of 20 tested across 69 trials, collagen hydrolysate, Boswellia and curcumin produced large short-term effects on pain, while glucosamine and chondroitin, the two most women take, produced improvements the reviewers called arguably clinically unimportant. A newer ranking of 4,599 patients puts Boswellia first and collagen among the group showing benefit without topping the list.
And none of it has been shown to still be working a year later. That is not a reason to take nothing. It is a reason to give anything you try a defined trial of a few months, judge it honestly, and put at least as much effort into the resistance training that the evidence supports more strongly than any tub on the shelf.
The aisle is not empty. It is just smaller than it looks.
Frequently asked questions
Which supplement has the strongest evidence for menopause joint pain?
For joint pain generally, Boswellia serrata has the strongest recent evidence, ranking highest for pain and stiffness in a 2025 network meta-analysis of 4,599 patients. Collagen hydrolysate and curcumin both produced large short-term effects in the broader 2018 review. For menopause joint pain specifically, no supplement has the strongest evidence, because none has been tested in that population.
Should I stop taking glucosamine?
Not necessarily. Across 69 trials it produced statistically significant pain improvement that reviewers judged of unclear clinical importance, which is weak rather than harmful, and its safety record is good. If you have taken it for months and noticed nothing, the evidence does not support continuing. If you notice a difference, that is worth more to you than a pooled average.
How long should I give a supplement before deciding it is not working?
The short-term results in these reviews generally come from trials of a few weeks to about three months, so that is the honest window. Judge it at three months. Continuing indefinitely with no noticeable change is not supported, and no supplement has demonstrated a clinically important effect on pain at long-term follow-up.
Can I take more than one at a time?
Nothing in these reviews suggests they interfere with each other, and no supplement studied caused more adverse events than placebo. The practical problem is that taking four things at once means you cannot tell which one, if any, is doing something. Adding one at a time and giving each a defined trial gives you information that a combined formula cannot.
Is joint pain in midlife definitely caused by menopause?
Not established. The prevalence data are observational, showing that joint pain and the menopausal transition occur together in a consistent pattern across 22 countries. Menopause also overlaps with a decade of ordinary ageing, and the review authors specifically call for higher-quality research to confirm the association. Persistent or one-sided joint pain deserves a diagnosis rather than an assumption.
Sources
- Kruse C, McKechnie T, Dworsky-Fried J, et al. (2026). Musculoskeletal manifestations of perimenopause: a systematic review and meta-analysis of 93,021 women. JB and JS Open Access 11(1):e25.00254. PMID 41523660. doi 10.2106/JBJS.OA.25.00254. pubmed.ncbi.nlm.nih.gov/41523660
- Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ (2018). Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. British Journal of Sports Medicine 52(3):167-175. PMID 29018060. doi 10.1136/bjsports-2016-097333. pubmed.ncbi.nlm.nih.gov/29018060
- Zhang Y, Gui Y, Adams R, et al. (2025). Comparative effectiveness of nutritional supplements in the treatment of knee osteoarthritis: a network meta-analysis. Nutrients 17(15):2547. PMID 40806131. doi 10.3390/nu17152547. pubmed.ncbi.nlm.nih.gov/40806131